Steven St. Peter

Steven St. Peter founded Vie Ventures, Inc. in 2026, where he is working as Managing Director from 2026, Aratana Therapeutics, Inc. in 2012, where he worked as President, Chief Executive Officer & Director from 2012 to 2019, and Vie Venture LLC in 2012, where he is working as Managing Director from 2012.
Dr. St. Peter also currently works at Kansas City Area Life Sciences Institute, Inc., as Director from 2014 and The Greater Kansas City Community Foundation, as Director from 2015.
Dr. St. Peter also formerly worked at iOmx Therapeutics AG, as Chairman - Supervisory Board from 2019 to 2020, Syndax Pharmaceuticals, Inc., as Director, A Breakthrough T1D Venture LLC, as Managing Director from 2019 to 2025, PharmAthene, Inc., as Director from 2007 to 2012, Aratana Therapeutics NV, as Managing Director & Director, Helicos Biosciences Corp., as Director, Rhythm Pharmaceuticals, Inc., as Director, MPM BioImpact LLC, as Managing Director from 2004 to 2012, New England Venture Capital Association, Inc., as Director, Omrix Biopharmaceuticals, Inc., as Director from 2004 to 2008, Xanodyne Pharmaceuticals, Inc., as Director, EKR Therapeutics, Inc., as Director, Proteon Therapeutics, Inc., as Director, MPM Asset Management LLC, as Managing Director in 2012, Allergan GI Corp., as Director, PharmAthene, Inc., as Director from 2004 to 2007, Apax Partners, Inc., as Principal from 2001 to 2003, Merrill Lynch & Co., Inc., as Principal, and Verus Pharmaceuticals, Inc., as Principal.
Dr. St. Peter received his Masters Business Admin degree in 1999 from The Wharton School of the University of Pennsylvania, doctorate degree in 1995 from the University of Washington, and undergraduate degree in 1989 from the University of Kansas.